{"id":"https://openalex.org/W4225941018","doi":null,"title":"PIK-75 overcomes venetoclax resistance via blocking PI3K-AKT signaling and MCL-1 expression in mantle cell lymphoma.","display_name":"PIK-75 overcomes venetoclax resistance via blocking PI3K-AKT signaling and MCL-1 expression in mantle cell lymphoma.","publication_year":2022,"publication_date":"2022-01-01","ids":{"openalex":"https://openalex.org/W4225941018","pmid":"https://pubmed.ncbi.nlm.nih.gov/35411248","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8984906"},"language":"en","primary_location":{"id":"pmid:35411248","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35411248","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8984906/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102378485","display_name":"Shengjian Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shengjian Huang","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100355813","display_name":"Yang Liu","orcid":"https://orcid.org/0000-0002-1910-8076","observed_orcids":["https://orcid.org/0000-0002-1910-8076"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yang Liu","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100430132","display_name":"Zhihong Chen","orcid":"https://orcid.org/0000-0002-9545-1327","observed_orcids":["https://orcid.org/0000-0002-9545-1327"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhihong Chen","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100438316","display_name":"Michael L. Wang","orcid":"https://orcid.org/0000-0001-9748-5486","observed_orcids":["https://orcid.org/0000-0001-9748-5486"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Wang","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA","Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068376154","display_name":"Changying Jiang","orcid":"https://orcid.org/0000-0003-3778-4438","observed_orcids":["https://orcid.org/0000-0003-3778-4438"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivian C Jiang","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":3.366,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.93502746,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":98},"biblio":{"volume":"12","issue":"3","first_page":"1102","last_page":"1115"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9276999831199646,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9276999831199646,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.03590000048279762,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.010300000198185444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9160000085830688},{"id":"https://openalex.org/keywords/venetoclax-resistance","display_name":"venetoclax resistance","score":0.9950000047683716},{"id":"https://openalex.org/keywords/pi3k-inhibition","display_name":"PI3K inhibition","score":0.7200000286102295},{"id":"https://openalex.org/keywords/cdk9-inhibition","display_name":"CDK9 inhibition","score":0.9750000238418579},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9100000262260437},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.9490000009536743},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.7870000004768372},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7089999914169312},{"id":"https://openalex.org/keywords/stromal-cells","display_name":"stromal cells","score":0.7509999871253967},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.6589999794960022},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.640999972820282},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6600000262260437},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.6959999799728394},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9809150695800781},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6818413734436035},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.6540284156799316},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5303065776824951},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.46654415130615234},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46389058232307434},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.4591189920902252},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2679600715637207},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.24465510249137878},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2404915988445282},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.21855014562606812},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.1955607831478119},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.17162799835205078},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11153033375740051},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07871103286743164}],"mesh":[],"locations_count":2,"locations":[{"id":"pmid:35411248","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35411248","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8984906","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8984906/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Am J Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:8984906","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8984906/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Am J Cancer Res","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1019028848","display_name":"Functional Proteomics by Reverse Phase Protein Array in Cancer","funder_award_id":"R50CA221675","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1818791232","https://openalex.org/W1876327798","https://openalex.org/W1957739887","https://openalex.org/W1970209296","https://openalex.org/W1972371148","https://openalex.org/W1982494540","https://openalex.org/W1992699251","https://openalex.org/W2011950935","https://openalex.org/W2024014530","https://openalex.org/W2028681024","https://openalex.org/W2059500638","https://openalex.org/W2060469376","https://openalex.org/W2066404900","https://openalex.org/W2128084665","https://openalex.org/W2133323723","https://openalex.org/W2154066874","https://openalex.org/W2192121806","https://openalex.org/W2291176625","https://openalex.org/W2338674998","https://openalex.org/W2339774970","https://openalex.org/W2521204548","https://openalex.org/W2529212447","https://openalex.org/W2582696216","https://openalex.org/W2594229189","https://openalex.org/W2620804057","https://openalex.org/W2730888200","https://openalex.org/W2737907117","https://openalex.org/W2741462465","https://openalex.org/W2794301068","https://openalex.org/W2800133359","https://openalex.org/W2900251625","https://openalex.org/W3096468185","https://openalex.org/W3184077719"],"related_works":["https://openalex.org/W2948282119","https://openalex.org/W3214887381","https://openalex.org/W4316467742","https://openalex.org/W2950610677","https://openalex.org/W4283160733","https://openalex.org/W2984284748","https://openalex.org/W2800133359","https://openalex.org/W4405052816","https://openalex.org/W4379981813","https://openalex.org/W2914107735"],"abstract_inverted_index":{"Therapeutic":[0],"resistance":[1,63,95,124,194,216,227,253,288],"is":[2,66,201,267,280,307],"the":[3,24,78,172,184,239],"major":[4],"challenge":[5],"in":[6,38,57,125,171,195,220,246,256,270,282,289,299,310,319,333],"clinic":[7,74],"for":[8,50],"patients":[9,52],"with":[10,53,59,93,121,140,224,248,341],"mantle":[11],"cell":[12,88,177,222,295],"lymphoma":[13],"(MCL),":[14],"an":[15,109],"aggressive":[16],"subtype":[17],"of":[18,132,145,154,166],"B-cell":[19],"lymphoma.":[20],"In":[21,264],"addition":[22],"to":[23,45,64,96,137,190,213,260,297,335],"FDA-approved":[25],"Bruton's":[26],"tyrosine":[27],"kinase":[28],"(BTK)":[29],"inhibitors,":[30],"multiple":[31],"clinical":[32,36,48],"trials":[33],"have":[34],"demonstrated":[35,304],"benefits":[37],"targeting":[39,206],"BCL-2":[40],"by":[41],"venetoclax":[42,65,82,97,123,193,215,226,252,275,287,317,342],"and":[43,69,91,101,127,148,151,157,175,180,209,229,243,254,285,292,322],"reported":[44],"greatly":[46],"improve":[47],"outcome":[49],"refractory/relapsed":[51],"MCL":[54,87,320,337],"alone":[55],"or":[56,250,314],"combination":[58],"BTK":[60],"inhibitors.":[61],"However,":[62],"no":[67],"exception":[68],"marks":[70],"as":[71],"a":[72,161,203,324],"new":[73,325],"challenge.":[75],"To":[76],"decode":[77],"underlying":[79],"mechanisms":[80],"driving":[81],"resistance,":[83],"we":[84,113,182],"established":[85],"two":[86],"lines,":[89],"Mino-Re":[90,126,179],"Rec1-Re,":[92,181],"acquired":[94,122,192,249,286],"from":[98],"sensitive":[99],"Mino":[100],"Rec-1.":[102],"Using":[103],"reverse":[104],"phase":[105],"protein":[106],"assay":[107],"(RPPA),":[108],"agnostic":[110],"proteomic":[111],"approach,":[112],"identified":[114,136,183],"targetable":[115],"signaling":[116],"pathways":[117],"that":[118,187,305,328],"are":[119,188],"associated":[120],"Rec1-Re":[128],"cells.":[129,197],"A":[130],"panel":[131],"pro-survival":[133],"signals":[134],"was":[135,217],"correlate":[138],"well":[139],"venetoclax-resistance,":[141],"including":[142],"increased":[143],"expression":[144,153,242],"MCL-1,":[146],"BCL-xL":[147],"AKT":[149,244],"phosphorylation,":[150],"decreased":[152],"BIM,":[155],"BAX":[156],"PTEN.":[158],"Based":[159],"on":[160],"high":[162],"throughput":[163],"drug":[164],"screening":[165],"over":[167],"320":[168],"FDA-approved/investigational":[169],"drugs":[170],"paired":[173],"venetoclax-sensitive":[174],"-resistant":[176],"lines":[178,223],"top":[185],"candidates":[186],"capable":[189],"overcome":[191,214,261],"these":[196,262],"The":[198],"best":[199],"candidate":[200],"PIK-75,":[202],"dual":[204],"inhibitor":[205],"both":[207],"PI3K":[208],"CDK9.":[210],"Its":[211],"action":[212],"further":[218],"confirmed":[219],"additional":[221],"primary":[225,230,251,284],"(n=4)":[228],"patient":[231],"samples":[232],"(n=21).":[233],"Mechanistically,":[234],"PIK75":[235,266],"treatment":[236,279],"potently":[237],"diminished":[238],"elevated":[240],"MCL-1":[241],"activation":[245],"cells":[247,321],"resulted":[255],"potent":[257,269,309],"anti-MCL":[258],"activity":[259],"resistances.":[263],"addition,":[265],"also":[268],"overcoming":[271,283,311],"tumor":[272,294,326],"microenvironment":[273],"(TME)-associated":[274],"resistance.":[276,343],"Furthermore,":[277],"PIK-75":[278,306],"efficacious":[281],"xenograft":[290],"models":[291],"inhibited":[293],"dissemination":[296],"spleen":[298],"mice.":[300],"Altogether,":[301],"our":[302],"data":[303],"highly":[308],"primary,":[312],"acquired,":[313],"stromal":[315],"cells-induced":[316],"resistances":[318],"revealed":[323],"vulnerability":[327],"can":[329],"be":[330],"exploited":[331],"clinically":[332],"difficult":[334],"treat":[336],"cases,":[338],"especially":[339],"those":[340]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-05-05T00:00:00"}